Molecular Templates Inc.

Plus: Amphista names Paul Medeiro CBO, and updates from Apellis, Forbion, Eqt, Egle, Spero, Molecular Templates and more

Newly independent cancer biotech looks to twin 2025 readouts of IL-2 program that leads pipeline of engineered cytokine therapeutics

Plus: Actinium hires Bodarky and updates from Summit, CentiVax, vTv and Calidi

Plus: updates from SparX, Breathe, Find and MedinCell

Plus: New CEOs named at Vivoryon and Kytopen, and updates from Avalyn, Ankyra, Indaptus and more 

Plus: Two new SVPs at Dragonfly, and updates from Abilita, OcuTerra and PineTree

Plus Kallyope promotes Pinto to CSO and updates from BD and Harpoon

New targets displaced validated mechanisms in first-in-human abstracts at ASCO 2022

Plus Werner named CEO at Alltrna, and updates from AptarGroup, MBX, Vesigen and more

Half the field is stuck in first gear, but a wealth of bispecifics, novel technologies are bringing new energy